Beam Therapeutics Overview

  • Founded
  • 2017
Founded
  • Status
  • Public
  • Employees
  • 24
Employees
  • Stock Symbol
  • BEAM
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $37.89
  • (As of Friday Closing)

Beam Therapeutics General Information

Description

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises of Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Potential Target
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 26 Landsdowne Street
  • 2nd Floor
  • Cambridge, MA 02139
  • United States

Beam Therapeutics Timeline

201820192020
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Beam Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$37.89 $35.51 $13.00 - $38.37 $1.96B 55.1M 677K -$3.17

Beam Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 1,223,892
Revenue 24 18 0
EBITDA (111,661) (77,122) (116,380)
Net Income (111,531) (78,326) (115,257)
Total Assets 299,975 156,099 167,012
Total Debt 36,191 31,238 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Beam Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Beam Therapeutics‘s full profile, request access.

Request a free trial

Beam Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Beam Therapeutics‘s full profile, request access.

Request a free trial

Beam Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technol
Biotechnology
Cambridge, MA
24 As of 2020
00000
0&0

00000000

p ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dol
0000000000000
Bedford, MA
000 As of 0000
00000
0000 0000-00-00
00000000 00000

00000000

cididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamc
0000000000000
Cambridge, MA
000 As of 0000
0000
000000 - 000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Beam Therapeutics Competitors (42)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Homology Medicines Formerly VC-backed Bedford, MA 000 00000 00000000 00000
00000000 000000000 Formerly VC-backed Cambridge, MA 000 0000 000000 - 000 0000
000000 00000000 Formerly VC-backed Cambridge, MA 000 00000 00000000000 00000
000000 00000000000 Formerly VC-backed Zug, Switzerland 000 00000 00000000000 00000
0000000 Formerly VC-backed Cambridge, MA 000 00000 000000 - 000 00000
You’re viewing 5 of 42 competitors. Get the full list »

Beam Therapeutics Executive Team (12)

Name Title Board Seat Contact Info
John Evans Chief Executive Officer & Board Member
Giuseppe Ciaramella Ph.D Chief Scientific Officer & President
Terry-Ann Burrell Chief Financial Officer, Finance & Treasurer, Finance
Susan O'Connor Chief Human Resources Officer
Christine Bellon Ph.D Senior Vice President and Chief Legal Officer
You’re viewing 5 of 12 executive team members. Get the full list »

Beam Therapeutics Board Members (8)

Name Representing Role Since
Carole Ho MD Self Board Member 000 0000
Graham Cooper Self Board Member 000 0000
John Evans Beam Therapeutics Chief Executive Officer & Board Member 000 0000
Kristina Burow ARCH Venture Partners Board Member 000 0000
Mark Fishman MD Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Beam Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Beam Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Beam Therapeutics‘s full profile, request access.

Request a free trial

Beam Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 000000000000 01-Sep-2018 000000000000000000 Biotechnology
To view Beam Therapeutics’s complete acquisitions history, request access »